期刊文献+

儿童糖尿病的强化治疗 被引量:4

暂未订购
导出
摘要 1型糖尿病(type 1 diabetes mellitus,T1DM)是儿童期常见的慢性疾病,世界各地T1DM患儿在显著增多,50%T1DM患者在15岁之前确诊。由于儿童带病生存的时间长于成人糖尿病患者,长期持续高血糖与微血管、大血管的并发症密切相关,因此治疗的目标是达到最佳的血糖控制,以延缓或防止血管并发症。儿童还必须保证正常的生长发育和生活质量,为了维持血糖接近正常,需要时时面对挑战。如何实现良好的血糖控制,使之可行并行之有效是我们探索的主题,强化治疗即为策略之一。
作者 吴迪 巩纯秀
出处 《中国医学前沿杂志(电子版)》 2012年第3期19-23,共5页 Chinese Journal of the Frontiers of Medical Science(Electronic Version)
基金 首都医学发展科研基金(2009-1046)
  • 相关文献

参考文献22

  • 1DCCT/EDIC Research Group,Nathan DM,Zinman B. Modern-day clinical course of type 1 diabetes mellitus after 30 year' s duration:The Diabetes Control and Complications Trial/Epidemiology of Diabetes Intervention and Complications and Pittsburgh Epidemiology of Diabetes Complications Experience(1983-2005)[J].Archives of Internal Medicine,2009,(04):1307-1316.
  • 2Braun D,Konrad D,Lang-Muritano M. Improved glycemic control and lower frequency of severe hypoglycemia with insulin detemir:long-term experience in 105 children and adolescents with type 1 diabetes[J].Pediatric Diabetes,2008,(part Ⅱ):382-387.
  • 3Toyoda M,Kinura M,Yamamoto N. Insulin glargine improves glycemic control and quality of lift in type 2 diabetic patients on hemodialysis[J].Journal of Nephrology,2012.
  • 4Shalitin S,Gil M,Nimiri R. Predictors of glycaemic control in patients with type 1 diabetes commencing continuous subcutaneous insulin infusion therapy[J].Diabetic Medicine,2010,(03):339-347.
  • 5Bergnstal RM,Tamberlane WV,Ahmann A. Effectiveness of sensor-augmented insulin pump therapy in type ldiabetes[J].New England Journal of Medicine,2010,(04):311-320.
  • 6Jakisch BI,Wagner VM,Heidtmann B. Comparison of continuous subcutaneous insulin infusion (CSII) and multiple daily injection (MDI) in paediatric type 1 diabetes:a multicenter matched-pair cohort analysis over 3 year[J].Diabetic Medicine,2008,(01):80-85.
  • 7Kordonouri O,Hartmann R,Lauterborn R. Age-specific advantages of continuous of subcutaneous insulin infusion (CSII) as compared with multiple daily injection (MDI) in pediatric patients:one year follow-up comparison by matchedpair analysis[J].Diabetes Care,2006,(01):133-134.
  • 8Nimiri R,Weitrob N,Benzaquen H. Insulin pump therapy in youth with type 1 diabetes:a retrospective paired study[J].Pediatrics,2006,(06):2126-2131.
  • 9Jeff Unger. Comparing the efficacy,safety and utility of intensive insulin algorithms for a primary care practice[J].Diabetes Ther,2011,(01):40-45.
  • 10Skinner TC,Cameron FJ. Improving glycaemic control in children and adolescent:which aspects of therapy really matter[J].Diabetic Medicine,2010,(04):369-375.

二级参考文献55

  • 1Bangstad HJ,Danne T,Deeb LC,et al.Insulin treatment in children and adolescents with diabetes.Pediatr Diabetes,2009,10 Suppl 12:82-99.
  • 2Heller SR,Colagiuri S,Vaaler S,et al.Hypoglycaemia with insulin aspart:a double-blind,randomised,crossover trial in subjects with Type 1 diabetes.Diabet Med,2004,21:769-775.
  • 3Danne T,R(a)stam J,Odendahl R,et al.Parental preference of prandial insulin aspart compared with preprandial human insulin in a basal-bolus scheme with NPH insulin in a 12-wk crossover study of preschool children with type 1 diabetes.Pediatr Diabetes,2007,8:278-285.
  • 4Heise T,Pieber TR.Towards peakless,reproducible and long-acting insulins.An assessment of the basal analogues based on isoglycasmic clamp studies.Diabetes Obes Metab,2007,9:648-659.
  • 5Robertson KJ,Schoenle E,Gucev Z,et al.Insulin detemir compared with NPH insulin in children and adolescents with Type 1 diabetes.Diabet Med,2007,24:27-34.
  • 6Schober E,Schoeule E,Van Dyk J,et al.Comparative trial between insulin glargine and NPH insulin in children and adolescents with type 1 diabetes.Diabetes Care,2001,24:2005-2006.
  • 7Heise T,Bott S,Rave K,et al.No evidence for accumulation of insulin glargine (LANTUS):a multiple injection study in patients with Type 1 diabetes.Diabet Med,2002,19:490-495.
  • 8Hamann A,Matthaei S,Rosak C,et al.A randomized clinical trial comparing breakfast,dinner,or bedtime administration of insulin glargine in patients with type 1 diabetes.Diabetes Care,2003,26:1738-1744.
  • 9Rather RE,Hirsch IB,Neifing JL,et al.Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes.U.S.Study Group of Insulin Glargine in Type 1 Diabetes.Diabetes Care,2000,23:639-643.
  • 10Thisted H,Johnsen SP,Rungby J.An update on the long-acting insulin analog glargine.Basic Clin Pharmacol Toxicol,2006,99:1-11.

共引文献38

同被引文献36

  • 1WINKLEY K, LAUDAU S, EISLER I, et al. Psychological inter- ventions to improve glycaemic control in patients with type 1 diabe- tes: systermatic review and meta - analysis of randomized con- trolled trials[J]. BMJ, 2006, 333(7558) : 65.
  • 2ROBLING M, MCNAMARA R, BENNERT K, et al. The effect of the Talking Diabetes consulting skills intervention on glycaemic control and quality of life in children with type 1 diabetes : cluster randomised controlled trial( DEPICTED study) [ J ]. BMJ, 2012, 344 : e2359.
  • 3巩纯秀.点燃希望--儿童糖尿病治疗指导[M].杭州:浙江科学教育出版社,2012.
  • 4American Diabetes Association. Diabetes managemeng at camps for children with diabetes[J]. Diabetes Care, 2012, 35( 1 ) : s72 - s75.
  • 5SCHMIDT C A, BERNAIX L W, CHIAPPETTA M, et al. In - hospital survival skills training for type 1 diabetes: perceptions of children and parents[J]. MCN Am J Matern Child Nuts, 2012, 37(2) : 88 -94.
  • 6EDGE J, ACKLAND F M, PAYNE S, et al. Inpatient Care for children with diabetes : are standards being met? [ J ]. Arch Dis Child, 2012, 97(7): 599-603.
  • 7BROWN S A, GARCIA A A, WINTER M, et al. Integrating Ed- ucation, Group Support, and Case Management for Diabetic His- panics[J]. Ethn Dis, 2011, 21(1): 20-26.
  • 8WEINHOLD K J. Empowering diabetic children. Camp Red Jacket makes a difference[J]. Healthc Exec, 2011, 26(5) : 66 -68.
  • 9HATUN S, BUNDAK R, OZBEK M N. The Pediatric Endocrinol- ogy Forum: Summer Camps for Diabetic Children in the Southeast- em Regions of Turkey[ J]. J Clin Res Pediatr Endocrinol, 2012, 4(1) : 49 -50.
  • 10Mohn A, Strang S, Wernicke-Panten K, el al. Nocturnal glucose control and free insulin levels in children with type 1 diabetes by use of the long-acting insulin HOE 901 as part of a three-injection regimen[J]. Diabetes Care, 2000, 23(4): 557-559.

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部